Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1Giuseppe Giaccone, David H. Johnson, Roy S. Herbst et al.|Journal of Clinical Oncology|2004Cited by 1.7k
Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung CancerJoachim von Pawel, Richard J. Gralla, Joan H. Schiller et al.|Journal of Clinical Oncology|1999Cited by 960
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung CancerChristopher G. Azzoli, Giuseppe Giaccone, Gregory A. Masters et al.|Journal of Clinical Oncology|2009Cited by 913
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung CancerLecia V. Sequist, Joan H. Schiller, Joachim von Pawel et al.|Journal of Clinical Oncology|2011Cited by 379